Scientists are analyzing hair to develop a new ALS diagnostic test
Analyzing single strands of hair has shown researchers that the dynamics of certain metal molecules, such as copper and zinc,…
Articles by Marisa Wexler, MS
Blood test could diagnose ALS years before symptoms appear: Study
Through analyses of blood samples from hundreds of patients, researchers have developed a highly accurate test for diagnosing amyotrophic…
Promising BCI tech can translate thoughts to speech for ALS patients
New research is bringing mind-to-speech technology a step closer to reality for people with paralysis, including those with amyotrophic…
This year’s ALS Nexus conference celebrated progress, shared hope
The second edition of ALS Nexus — a conference hosted earlier this month in Dallas by the ALS…
Scientists reverse cell aging in mice, delaying ALS onset
Genetically reprogramming nerve cells to reverse aging may be a viable strategy for treating amyotrophic lateral sclerosis (ALS), a…
Research sheds new light on ALS gene mutation
Researchers at Yale School of Medicine said they’ve solved a longstanding mystery of how mutations in the C9ORF72 gene, a common…
Wearable robot gives ALS patients a hand
A wearable robot that detects small arm motions and helps support the shoulder can make it easier for amyotrophic…
Measuring electrical activity of neck muscles may be new tool in ALS
Measuring the electrical activity of muscles in the neck can help clinicians to identify dysfunction in certain motor neurons —…
Advocates ask for new FDA review of stem cell therapy NurOwn
A coalition of amyotrophic lateral sclerosis (ALS) patients and their family members has filed a petition to the U.S.
9 of 10 NurOwn-treated ALS patients surpass five-year survival
Nine out of 10 people with amyotrophic lateral sclerosis (ALS) who received the experimental cell therapy NurOwn (debamestrocel)…